Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.49 |
| ▸ | CNR2 | P34972 | 12/20 | 0.48 |
| ▸ | CNR1 | P21554 | 11/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.47 |
| ▸ | MLNR | O43193 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | PDE9A | O76083 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17124386 | 1.00 | OPRM1 (0.49) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681864 | 1.00 | OPRM1 (0.49) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681816 | 1.00 | OPRM1 (0.49) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL17124390 | 0.99 | OPRM1 (0.49) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL17124389 | 0.96 | CNR1 (0.49) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681817 | 0.93 | CNR2 (0.43) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681814 | 0.93 | CNR2 (0.43) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681815 | 0.93 | CNR2 (0.43) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681813 | 0.92 | CNR1 (0.44) | OPRM1CNR2CNR1DRD3TRPV1 | |
| SCHEMBL15681865 | 0.91 | CNR2 (0.43) | OPRM1CNR2CNR1TRPV1GPR55 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9517989-B2 | 2-cycloalkyl resorcinol cannabinergic ligands | NORTHEASTERN UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150274623-A1 | 2-CYCLOALKYL RESORCINOL CANNABINERGIC LIGANDS | Northeastern Uiversity (US) | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274623-A1 | 2-CYCLOALKYL RESORCINOL CANNABINERGIC LIGANDS | CNR2, CNR1, OPRL1 | OPRM1 61/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.